FDA Warning Letter Sinks Intuitive Surgical Shares

Sales of its da Vinci system fell during the second quarter

   

Intuitive Surgical 300x125 FDA Warning Letter Sinks Intuitive Surgical Shares Shares of Intuitive Surgical (ISRG) plunged more than 12% in Friday morning trading after federal regulators advised the company of problems noted during a second-quarter inspection of its facilities.

Intuitive, which manufactures robotic surgical equipment, said that the U.S. Food and Drug Administration (FDA), which announced an investigation of the company in February, had requested that it correct the problems. The company said it would comply with the FDA’s requests, the Associated Press notes.

caduceus 200x200 FDA Warning Letter Sinks Intuitive Surgical Shares
3 Medical Devices Stocks to Sell Now

The company noted that sales of its da Vinci surgical system, which allows surgeons to perform surgery through small incisions with robotic arms and remote sensors, had dropped during second quarter. It expects slower sales for the remainder of the year.

For the quarter, Intuitive said it earned $159.1 million, up 3% compared to the same time last year. Sales climbed to $536.5 million, up 8%. The results were consistent with analysts’ already lowered forecasts.


Article printed from InvestorPlace Media, http://investorplace.com/2013/07/fda-warning-letter-sinks-intuitive-surgical-shares/.

©2014 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.